GO:0046514 ceramide catabolic process: Sphingolipid Breakdown, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046514 ceramide catabolic process describes the biochemical breakdown of ceramides, N-acetylated sphingoid bases, into downstream metabolites such as sphingosine, fatty acids, and sphingosine-1-phosphate.
• Ceramide catabolism is not merely a degradative endpoint; it generates bioactive lipids that control exosome secretion, membrane domain organization, and mitochondrial permeabilization.
• Key enzymes include acid and neutral ceramidases (ASAH1, ASAH2), sphingosine kinases (SPHK1/2), and ceramide synthases (CERS1-6) that interconvert ceramide species.
• Dysregulated ceramide catabolism is implicated in skin barrier disorders, acute kidney injury, brain ischemia, and mitochondrial inflammatory signaling.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of ceramide catabolic enzymes in disease-relevant cell types.
• Researchers can map ceramide catabolic flux using lipidomics, isotope tracing, and CRISPR library screening coupled to bioinformatic pathway analysis.
Description
Ceramides are central sphingolipids that serve both as structural membrane components and as signaling molecules controlling cell fate, inflammation, and vesicle trafficking. The Gene Ontology term GO:0046514, ceramide catabolic process, defines the chemical reactions and pathways that break down ceramides, any N-acetylated sphingoid, into downstream products. This process is essential for maintaining sphingolipid homeostasis and for generating bioactive lipids such as sphingosine and sphingosine-1-phosphate, which regulate proliferation, differentiation, and apoptosis. Beyond basic lipid metabolism, ceramide catabolism directly influences membrane organization and intercellular communication. For example, ceramide catabolism and ceramide-enriched membrane domain dynamics regulate exosome budding into multivesicular endosomes, a process critical for extracellular vesicle signaling. In the brain, ceramide accumulation and mitochondrial permeabilization can trigger mtDNA-dependent inflammation in astrocytes during ischemia, linking catabolic imbalance to neuroinflammation. In skin, ceramide catabolism and biosynthesis jointly determine epidermal permeability barrier function, with clinical implications for dermatological disease. For researchers, GO:0046514 provides a structured framework to study how cells degrade ceramides, which enzymes execute each step, and how catabolic flux is rewired in disease. Understanding this process at the gene, protein, and pathway level is prerequisite for developing targeted interventions in cancer, metabolic disorders, kidney injury, and neurodegeneration.
ceramide catabolic process At A Glance
| GO ID | GO:0046514 |
|---|---|
| GO term | ceramide catabolic process |
| Ontology | biological_process |
| Synonym | ceramide breakdown; ceramide catabolism; ceramide degradation |
| Major function | Breakdown of ceramides into sphingosine, fatty acids, and downstream sphingolipid metabolites |
| Key enzymes | ASAH1, ASAH2, SPHK1, SPHK2, CERS1-6, SMPD1 |
| Cellular location | Lysosome, plasma membrane, mitochondria, endoplasmic reticulum, Golgi |
| Pathway context | Sphingolipid metabolism; ceramide signaling; exosome biogenesis |
| Disease relevance | Skin barrier disorders, acute kidney injury, brain ischemia, cancer, metabolic disease |
What Is GO:0046514?
GO:0046514 ceramide catabolic process is the biological process comprising the chemical reactions and pathways that result in the breakdown of ceramides, defined as any N-acetylated sphingoid. This includes enzymatic hydrolysis of the amide bond to release sphingosine and fatty acid, subsequent phosphorylation of sphingosine, and further catabolic conversions that terminate ceramide signaling and recycle sphingolipid precursors.
Why Is ceramide catabolic process Important in Cell Biology?
Ceramide catabolic process is important because it determines the cellular balance between pro-apoptotic, pro-inflammatory ceramides and their downstream metabolites, which have distinct and sometimes opposing biological activities. This balance controls membrane domain organization, exosome secretion, mitochondrial homeostasis, and inflammatory signaling, making GO:0046514 a central node in cell stress responses and disease pathogenesis.
• Regulates the steady-state levels of ceramides, which are key mediators of apoptosis and stress responses.
• Generates sphingosine and sphingosine-1-phosphate, bioactive lipids controlling proliferation, migration, and immune cell trafficking.
• Controls exosome biogenesis and extracellular vesicle release through ceramide-enriched membrane domains.
• Modulates mitochondrial permeabilization and mtDNA-dependent inflammation in astrocytes during brain ischemia.
• Impacts epidermal permeability barrier function and skin health, with relevance to dermatological disease.
• Is implicated in acute kidney injury through altered sphingolipid catabolic flux.
• Provides metabolic intermediates for membrane remodeling and stress adaptation.
• Offers therapeutic targets for cancer, neurodegeneration, and metabolic disorders.
• Enables mechanistic studies using CRISPR screens and lipidomics to map catabolic enzyme networks.
• Serves as a biomarker axis for disease severity in skin, kidney, and brain pathologies.
What Happens During ceramide catabolic process?
Ceramide hydrolysis by ceramidases
In simple terms: Ceramidases cut ceramide into sphingosine and fatty acid.
The first committed step in ceramide catabolism is hydrolysis of the amide bond by ceramidases, including acid ceramidase ASAH1 and neutral ceramidase ASAH2, yielding sphingosine and a free fatty acid. This reaction reduces ceramide levels and generates sphingosine, which can be phosphorylated or further degraded.
Sphingosine phosphorylation and sphingosine-1-phosphate formation
In simple terms: Sphingosine is converted into a signaling lipid called S1P.
Sphingosine produced by ceramidase activity is phosphorylated by sphingosine kinases SPHK1 and SPHK2 to form sphingosine-1-phosphate (S1P), a potent signaling lipid that regulates cell survival, migration, and immune responses. This step links ceramide catabolism to extracellular signaling and vascular biology.
Ceramide-enriched membrane domain remodeling
In simple terms: Breaking down ceramide changes how membranes are organized into signaling platforms.
Ceramide catabolism alters the composition of ceramide-enriched membrane domains, which are specialized signaling platforms that cluster receptors and enzymes. Changes in catabolic flux can disrupt these domains and affect downstream signaling, including exosome budding into multivesicular endosomes.
Mitochondrial permeabilization and inflammatory signaling
In simple terms: Ceramide breakdown products can stress mitochondria and trigger inflammation.
Ceramide catabolic imbalance and ceramide accumulation increase mitochondrial permeabilization, leading to release of mitochondrial DNA and mtDNA-dependent inflammation in astrocytes during brain ischemia. This connects GO:0046514 to mitochondrial homeostasis and neuroinflammatory pathways.
Integration with sphingolipid salvage and recycling
In simple terms: Breakdown products are reused to build new sphingolipids.
Catabolic products of ceramide, including sphingosine and fatty acids, can be recycled into sphingolipid biosynthesis through salvage pathways involving ceramide synthases CERS1-6. This integration ensures metabolic flexibility and membrane lipid homeostasis.
Key Genes Involved in GO:0046514 ceramide catabolic process
The following genes and proteins are experimentally implicated in ceramide catabolic process and its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ASAH1 | Acid ceramidase hydrolyzes ceramide to sphingosine and fatty acid | Lysosomal ceramide catabolism; disease models of Farber disease and cancer |
| ASAH2 | Neutral ceramidase catalyzes ceramide hydrolysis at neutral pH | Plasma membrane and extracellular ceramide catabolism |
| SPHK1 | Phosphorylates sphingosine to sphingosine-1-phosphate | Links ceramide catabolism to S1P signaling and cell survival |
| SPHK2 | Phosphorylates sphingosine, nuclear and mitochondrial roles | Regulates sphingosine-1-phosphate in stress responses |
| CERS1 | Ceramide synthase isoform involved in ceramide biosynthesis and salvage | Balances catabolic and anabolic sphingolipid flux |
| CERS2 | Ceramide synthase with distinct acyl-chain specificity | Determines ceramide species composition and catabolic targeting |
| CERS3 | Ceramide synthase important in skin barrier lipids | Epidermal permeability barrier and skin disease models |
| CERS4 | Ceramide synthase contributing to long-chain ceramides | Sphingolipid homeostasis and membrane dynamics |
| CERS5 | Ceramide synthase involved in mitochondrial ceramide pools | Mitochondrial homeostasis and stress signaling |
| CERS6 | Ceramide synthase linked to C16 ceramide synthesis | Ceramide species-specific catabolism and disease |
| SMPD1 | Acid sphingomyelinase generates ceramide from sphingomyelin | Upstream of ceramide catabolic process; lysosomal storage disease models |
| SGMS1 | Sphingomyelin synthase produces sphingomyelin from ceramide | Counterbalances ceramide catabolism in membrane homeostasis |
| ACER1 | Alkaline ceramidase hydrolyzes ceramide | Ceramide catabolism in skin and stress responses |
| ACER2 | Alkaline ceramidase involved in sphingosine generation | Sphingosine-1-phosphate production and cell fate |
| ACER3 | Alkaline ceramidase with broad substrate specificity | Ceramide catabolism and lipid signaling |
| DEGS1 | Dihydroceramide desaturase converts dihydroceramide to ceramide | Upstream ceramide pool generation for catabolism |
| UGCG | Glucosylceramide synthase uses ceramide for glycosphingolipids | Competes with catabolism for ceramide substrate |
| NPC1 | Cholesterol and sphingolipid trafficking protein | Lysosomal lipid handling and ceramide catabolism context |
How Is ceramide catabolic process Regulated?
Ceramide catabolic process is regulated at multiple levels, including enzyme expression, post-translational modification, and substrate availability. Sphingosine kinases SPHK1 and SPHK2 are regulated by growth factors and stress signals, controlling the conversion of sphingosine to sphingosine-1-phosphate. Ceramide synthases CERS1-6 determine the acyl-chain composition of ceramide pools, which in turn influences which ceramides are available for catabolism. In skin, nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids, indirectly affecting catabolic balance and barrier function. Mitochondrial homeostasis pathways intersect with ceramide catabolism, as ceramide accumulation can trigger mitochondrial permeabilization and mtDNA-dependent inflammation. Additionally, ceramide-enriched membrane domains provide spatial regulation by concentrating enzymes and substrates.
ceramide catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ASAH1 | Farber disease; lysosomal ceramide catabolism defects | Knockout and point-mutation cell models; lipidomics |
| ASAH2 | Ceramide catabolism in kidney and metabolic stress | Knockout in renal tubular cells; acute kidney injury models |
| SPHK1 | Cancer cell survival and S1P signaling | Overexpression and knockout in cancer cell lines |
| SPHK2 | Neuroinflammation and mitochondrial stress | Knockout in astrocytes; brain ischemia models |
| CERS3 | Skin barrier disorders and epidermal permeability | Knockout keratinocyte models; barrier function assays |
Ceramide catabolism in skin barrier disorders
Ceramides are essential for epidermal permeability barrier function, and altered ceramide catabolism contributes to skin diseases characterized by barrier dysfunction. Nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids, improving the epidermal permeability barrier, indicating that modulating ceramide metabolism has therapeutic potential. Dysregulation of ceramide catabolic enzymes such as ASAH1 and ACER1 may shift the balance between structural ceramides and signaling sphingosine-1-phosphate in skin.
Ceramide catabolism and acute kidney injury
Altered sphingolipid metabolism, including ceramide catabolic flux, is implicated in acute kidney injury. Ceramide accumulation and downstream signaling can promote tubular cell stress and inflammation, making catabolic enzymes potential targets for renoprotective strategies. Experimental models of acute kidney injury can be used to test whether modulating ASAH1, ASAH2, or SPHK1/2 alters injury severity.
Ceramide catabolism in brain ischemia and neuroinflammation
During brain ischemia, ceramides increase mitochondrial permeabilization in astrocytes, triggering mtDNA-dependent inflammation. This links ceramide catabolic imbalance to neuroinflammatory cascades and suggests that enzymes controlling ceramide breakdown could be targeted to reduce ischemic brain injury. Astrocyte models are particularly useful for dissecting this mechanism.
Ceramide catabolism in cancer and metabolic disease
Ceramide catabolism influences cell survival and proliferation through generation of sphingosine-1-phosphate, which can promote tumor growth and survival. Conversely, ceramide accumulation promotes apoptosis, so catabolic enzymes such as ASAH1 and SPHK1 are considered therapeutic targets in cancer. Metabolic disorders also involve altered sphingolipid flux, and CRISPR models can help define causal roles of specific catabolic genes.
From ceramide catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ASAH1 alter ceramide catabolic flux? | ASAH1 knockout cell line with lipidomics |
| Does a point mutation in SPHK1 affect S1P generation? | SPHK1 point-mutation knock-in cells |
| Can tagged ASAH2 track subcellular localization? | Tagged knock-in of ASAH2 in epithelial cells |
| Does overexpression of SPHK2 protect against ischemia? | SPHK2 overexpression in astrocyte models |
| Which genes regulate ceramide catabolism in skin? | CRISPR library screening in keratinocytes |
| Does CERS3 knockout impair barrier function? | CERS3 knockout keratinocytes and barrier assays |
How to Study the ceramide catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS/MS) | Ceramide, sphingosine, S1P levels | Quantifying catabolic flux after gene perturbation |
| CRISPR knockout | Loss-of-function effects on ceramide catabolism | Testing causal roles of ASAH1, ASAH2, SPHK1/2 |
| Point-mutation knock-in | Catalytic and regulatory residue function | Dissecting enzyme mechanism |
| Isotope tracing | Metabolic flux through catabolic pathway | Mapping sphingolipid recycling |
| Fluorescence imaging | Membrane domain and exosome dynamics | Studying ceramide-enriched domains |
| CRISPR library screening | Genome-wide regulators of ceramide catabolism | Identifying novel pathway genes |
| Bioinformatic pathway analysis | Enrichment of sphingolipid catabolic genes | Interpreting omics datasets |
| Mitochondrial permeability assays | mtDNA release and inflammation | Brain ischemia astrocyte models |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics quantifies ceramide species, sphingosine, and sphingosine-1-phosphate to measure catabolic flux. This method is essential for determining how genetic perturbations alter ceramide catabolic process.
CRISPR knockout and point-mutation models
CRISPR knockout of ASAH1, ASAH2, SPHK1, or SPHK2 enables causal testing of their roles in ceramide catabolism. Point-mutation knock-in can dissect catalytic residues and regulatory phosphorylation sites.
Isotope tracing and metabolic flux analysis
Stable isotope tracing with labeled sphingoid bases or fatty acids allows researchers to follow catabolic intermediates and quantify pathway activity. This approach links genotype to metabolic phenotype.
Imaging and membrane domain analysis
Fluorescence imaging of ceramide-enriched membrane domains and exosome markers reveals how catabolic changes affect membrane organization and vesicle budding. This is particularly useful for studying exosome biogenesis.
How CRISPR Can Be Used to Study GO:0046514 ceramide catabolic process
Knockout
CRISPR knockout of ceramide catabolic genes such as ASAH1, ASAH2, SPHK1, and SPHK2 provides definitive loss-of-function models to test their roles in sphingolipid homeostasis and disease. Knockout cells can be profiled by lipidomics to quantify ceramide accumulation and downstream metabolite depletion.
Point Mutation
Point-mutation knock-in allows precise dissection of catalytic residues and regulatory sites in ceramidases and sphingosine kinases. For example, mutating the catalytic cysteine of ASAH1 can separate enzymatic activity from scaffolding functions.
Knock-in
Tagged knock-in of catabolic enzymes enables live-cell imaging and proteomic interaction studies without overexpression artifacts. This is valuable for tracking enzyme localization to membrane domains and mitochondria.
Overexpression
Overexpression of SPHK1, SPHK2, or ASAH1 can model gain-of-function states observed in cancer and inflammatory disease. Overexpression models help determine whether increased catabolic flux is sufficient to drive phenotypic changes.
How EDITGENE Supports ceramide catabolic process Research
Researchers studying ceramide catabolic process-related genes often need to determine whether a candidate gene is causally involved in sphingolipid breakdown, disease progression, or therapeutic response. EDITGENE provides publication-ready CRISPR cell models and screening services to accelerate this causal dissection.
Contact EDITGENE today to design your custom CRISPR model for ceramide catabolic process research.
Frequently Asked Questions About ceramide catabolic process
What is GO:0046514 ceramide catabolic process?
GO:0046514 is the Gene Ontology term for the chemical reactions and pathways that break down ceramides, any N-acetylated sphingoid, into sphingosine, fatty acids, and downstream metabolites.
What genes are involved in ceramide catabolic process?
Key genes include ASAH1, ASAH2, ACER1-3, SPHK1, SPHK2, and CERS1-6, which encode enzymes that hydrolyze, phosphorylate, or recycle ceramides.
Why is ceramide catabolism important in disease?
Ceramide catabolism controls levels of pro-apoptotic ceramides and pro-survival sphingosine-1-phosphate, influencing skin barrier function, kidney injury, brain ischemia, and cancer.
How does ceramide catabolism affect exosomes?
Ceramide catabolism and ceramide-enriched membrane domains regulate budding of exosome vesicles into multivesicular endosomes, affecting extracellular vesicle signaling.
What is the role of ASAH1 in ceramide catabolism?
ASAH1 encodes acid ceramidase, which hydrolyzes ceramide into sphingosine and fatty acid in lysosomes, a key step in ceramide catabolic process.
How do SPHK1 and SPHK2 regulate ceramide catabolism?
SPHK1 and SPHK2 phosphorylate sphingosine generated from ceramide breakdown to produce sphingosine-1-phosphate, linking catabolism to cell survival signaling.
Can CRISPR knockout be used to study ceramide catabolic genes?
Yes, CRISPR knockout of ASAH1, ASAH2, SPHK1, or SPHK2 enables loss-of-function studies of ceramide catabolism and its disease relevance.
What methods measure ceramide catabolic flux?
Lipidomics, isotope tracing, and mass spectrometry quantify ceramide, sphingosine, and S1P levels to assess catabolic flux.
Is ceramide catabolism linked to mitochondrial inflammation?
Yes, ceramide accumulation increases mitochondrial permeabilization and mtDNA-dependent inflammation in astrocytes during brain ischemia.
How does nicotinamide affect ceramide metabolism in skin?
Nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids, improving epidermal permeability barrier function.
Conclusion
GO:0046514 ceramide catabolic process is a central metabolic pathway that controls the balance between ceramides and their bioactive products, with far-reaching consequences for membrane organization, exosome biology, mitochondrial homeostasis, and inflammation. Its dysregulation is implicated in skin barrier disorders, acute kidney injury, brain ischemia, and cancer, making it a high-value target for mechanistic and therapeutic research. By combining CRISPR knockout, point-mutation, knock-in, overexpression models, and CRISPR library screening with lipidomics and bioinformatics, researchers can causally dissect ceramide catabolic networks and accelerate translation to human disease.
References
- 1. Trajkovic K et al.. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes.. Science 319(5867):1244-7 PMID: 18309083
- 2. Uchida Y et al.. 2021. Ceramides in Skin Health and Disease: An Update.. Am J Clin Dermatol 22(6):853-866 PMID: 34283373
- 3. Huang FQ et al.. 2025. Ceramides increase mitochondrial permeabilization to trigger mtDNA-dependent inflammation in astrocytes during brain ischemia.. Metabolism 166:156161 PMID: 39956315
- 4. Hannun YA et al.. 2011. Many ceramides.. J Biol Chem 286(32):27855-62 PMID: 21693702
- 5. Bollinger CR et al.. 2005. Ceramide-enriched membrane domains.. Biochim Biophys Acta 1746(3):284-94 PMID: 16226325
- 6. Ding S et al.. 2024. Ceramides and mitochondrial homeostasis.. Cell Signal 117:111099 PMID: 38360249
- 7. Nicholson RJ et al.. 2022. Ceramides and Acute Kidney Injury.. Semin Nephrol 42(3):151281 PMID: 36404212
- 8. Tanno O et al.. 2000. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier.. Br J Dermatol 143(3):524-31 PMID: 10971324
